Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Complete Obstruction of Proximal Left Ascending Artery in a Very Young Woman With Kawasaki: A Case Report and Literature Review Publisher Pubmed



Ebrahimi P1 ; Mandegar MH2 ; Nasrollahizadeh A1 ; Soltani P1 ; Soleimani H3 ; Ramezani P4 ; Naderi F5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Cardiovascular Surgery, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, 8174673461, Iran

Source: Journal of Cardiothoracic Surgery Published:2025


Abstract

Introduction: Kawasaki disease is a predisposing factor for various potentially fatal anomalies that can cause coronary artery diseases in childhood, adolescence, or adulthood if they are not appropriately treated, usually done with ASA and intravenous immunoglobulin (IVIG). This study presents a case of a young woman who needed a coronary artery bypass graft (CABG) due to a history of Kawasaki and coronary artery severe stenosis. Case presentation: A 24-year-old woman presented with chest pain, exertional and at-rest dyspnea, lower limb edema, and crackle at bilateral lung bases. After stabilization, it was noted that her left anterior descending artery (LAD) had been obstructed completely. She underwent CABG successfully and recovered uneventfully. The six-month follow-up showed almost complete. His medical therapy continued with dual antiplatelet therapy, statin, diuretics, spironolactone, and some other medications to decline the process of her heart structural change ( © The Author(s) 2025.